ReviewDiabetes/metabolism research and reviews2026
Algor-Ethics in Diabetes Care: Mapping the Route.
Review in Diabetes/metabolism research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus represents a multifaceted global health challenge, frequently coexisting with obesity, cardiovascular complications, and metabolic disorders. Effective management requires individualised, evidence-based decisions informed by an array of clinical, genetic, and lifestyle data. With the rapid growth of digital health technologies, artificial intelligence (AI) and algorithmic systems have emerged as powerful tools to support clinicians in diagnosis, treatment planning, and risk stratification. While AI shows promise in improving diabetes outcomes and health system efficiency, its integration into patient care is not without ethical and epistemic challenges. Algorithmic decision-making can influence therapeutic strategies, sometimes without full transparency or adequate oversight, potentially compromising human values such as autonomy, justice, and trust. In this context, the discipline of 'Algor-ethics', a term coined to describe the intersection of algorithmic systems and ethical principles, becomes critical. This article explores the foundational concepts of Algor-ethics applied to diabetes care, analyzes the current state of AI integration, and highlights the epistemic and ethical implications of algorithmic decision-making. Emphasis is placed on developing a framework that ensures AI is implemented safely, equitably, and responsibly, particularly for complex patients with diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.